Veru Inc. SEC filings VERU
Veru Inc. has 1,000 filings in SEC EDGAR's recent list, going back to May 14, 2007. Its latest annual report, Form 10-K, was filed on Dec 17, 2025 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 8, 2026 (other events). The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Sep 8, 2026 | Sep 8, 2026 |
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Material agreement
|
Jul 2, 2026 | Jul 2, 2026 |
| 424B5 | Prospectus supplement | Jul 2, 2026 | — |
| 8-K |
Current report
Other events
|
Jun 4, 2026 | Jun 2, 2026 |
| S-8 | Employee stock plan registration | May 13, 2026 | — |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 13, 2026 | May 13, 2026 |
| EFFECT | Filing | Apr 15, 2026 | — |
| EFFECT | Filing | Apr 15, 2026 | — |
| CORRESP | Letter to the SEC | Apr 13, 2026 | — |
| CORRESP | Letter to the SEC | Apr 13, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 13, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 13, 2026 | — |
| S-3 | Shelf registration | Apr 7, 2026 | — |
| S-3 | Shelf registration | Apr 7, 2026 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Mar 13, 2026 | Mar 12, 2026 |
| 10-Q | Quarterly report | Feb 11, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 11, 2026 | Feb 11, 2026 |
| DEFA14A | Additional proxy material | Jan 28, 2026 | — |
| DEF 14A | Proxy statement | Jan 28, 2026 | Mar 12, 2026 |
| S-8 | Employee stock plan registration | Dec 17, 2025 | — |
| 10-K | Annual report | Dec 17, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Dec 17, 2025 | Dec 17, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 30, 2025 | Oct 29, 2025 |
| 424B5 | Prospectus supplement | Oct 30, 2025 | — |
| 424B5 | Prospectus supplement | Oct 29, 2025 | — |
| 8-K |
Current report
Agreement ended
|
Sep 26, 2025 | Sep 22, 2025 |
| 8-K |
Current report
Other events
|
Aug 27, 2025 | Aug 26, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Aug 12, 2025 | Aug 8, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jul 25, 2025 | Jul 25, 2025 |
| DEFA14A | Additional proxy material | Jul 15, 2025 | — |
| DEFA14A | Additional proxy material | Jun 10, 2025 | — |
| DEF 14A | Proxy statement | Jun 10, 2025 | Jul 25, 2025 |
| PRE 14A | Preliminary proxy statement | May 9, 2025 | Jul 25, 2025 |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Mar 14, 2025 | Mar 13, 2025 |
| 8-K |
Current report
Listing notice
|
Feb 28, 2025 | Feb 27, 2025 |
| 10-Q | Quarterly report | Feb 13, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 13, 2025 | Feb 13, 2025 |
| DEFA14A | Additional proxy material | Jan 28, 2025 | — |
| DEF 14A | Proxy statement | Jan 28, 2025 | Mar 13, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended, Acquisition or sale of assets, Other events
|
Jan 3, 2025 | Dec 30, 2024 |
| EFFECT | Filing | Dec 16, 2024 | — |
| 10-K | Annual report | Dec 16, 2024 | Sep 30, 2024 |
| POS AM | Filing | Dec 12, 2024 | — |
| 8-K |
Current report
Material agreement
|
Sep 20, 2024 | Sep 19, 2024 |
| 8-K |
Current report
Listing notice
|
Aug 30, 2024 | Aug 29, 2024 |
| 8-K |
Current report
Agreement ended
|
Aug 23, 2024 | Aug 19, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Officer or director change
|
Aug 2, 2024 | Aug 1, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jul 2, 2024 | Jun 27, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2024 | Jun 18, 2024 |
| DEFA14A | Additional proxy material | Jun 20, 2024 | — |
| DEFA14A | Additional proxy material | Jun 18, 2024 | — |
| 8-K |
Current report
Auditor change
|
May 22, 2024 | May 16, 2024 |
| DEFA14A | Additional proxy material | May 9, 2024 | — |
| DEFR14A | Filing | May 9, 2024 | — |
| 10-Q | Quarterly report | May 8, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 8, 2024 | May 8, 2024 |
| 8-K |
Current report
Material agreement
|
Apr 26, 2024 | Apr 24, 2024 |
| 8-K |
Current report
Other events
|
Apr 25, 2024 | Apr 23, 2024 |
| DEFA14A | Additional proxy material | Apr 1, 2024 | — |
| 10-Q | Quarterly report | Apr 1, 2024 | Dec 31, 2023 |
| 10-K/A | Amended annual report | Apr 1, 2024 | Sep 30, 2023 |
| DEFA14A | Additional proxy material | Mar 22, 2024 | — |
| 8-K |
Current report
Listing notice
|
Feb 28, 2024 | Feb 21, 2024 |
| NT 10-Q | Filing | Feb 15, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Restatement
|
Feb 15, 2024 | Feb 15, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 8, 2024 | Feb 8, 2024 |
| 8-K |
Current report
Listing notice
|
Jan 26, 2024 | Jan 25, 2024 |
| DEFA14A | Additional proxy material | Jan 26, 2024 | — |
| DEF 14A | Proxy statement | Jan 26, 2024 | Mar 26, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Dec 18, 2023 | Dec 14, 2023 |
| 424B5 | Prospectus supplement | Dec 15, 2023 | — |
| 424B5 | Prospectus supplement | Dec 13, 2023 | — |
| 424B5 | Prospectus supplement | Dec 13, 2023 | — |
| 8-K |
Current report
Material agreement, Other events
|
Dec 13, 2023 | Dec 13, 2023 |
| 10-K | Annual report | Dec 8, 2023 | Sep 30, 2023 |
| 10-Q/A | Amended quarterly report | Nov 15, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Restatement
|
Nov 15, 2023 | Nov 10, 2023 |
| 8-K |
Current report
Material agreement
|
Oct 2, 2023 | Sep 29, 2023 |
| 8-K |
Current report
Other events
|
Sep 11, 2023 | Sep 11, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jul 28, 2023 | Jul 24, 2023 |
| DEFA14A | Additional proxy material | Jun 12, 2023 | — |
| DEF 14A | Proxy statement | Jun 12, 2023 | Jul 24, 2023 |
| EFFECT | Filing | May 24, 2023 | — |
| CORRESP | Letter to the SEC | May 22, 2023 | — |
| UPLOAD | Letter from the SEC | May 19, 2023 | — |
| PRE 14A | Preliminary proxy statement | May 15, 2023 | Jul 24, 2023 |
| S-3 | Shelf registration | May 12, 2023 | — |
| 8-K |
Current report
Material agreement
|
May 12, 2023 | May 12, 2023 |
| 424B5 | Prospectus supplement | May 12, 2023 | — |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 8-K |
Current report
Material agreement
|
May 3, 2023 | May 2, 2023 |
| 424B5 | Prospectus supplement | May 3, 2023 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets
|
Apr 20, 2023 | Apr 19, 2023 |
| EFFECT | Filing | Apr 14, 2023 | — |
| CORRESP | Letter to the SEC | Apr 13, 2023 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Apr 13, 2023 | Apr 12, 2023 |
| 8-K |
Current report
Other events
|
Apr 12, 2023 | Apr 11, 2023 |
| S-3/A | Filing | Apr 11, 2023 | — |
| CORRESP | Letter to the SEC | Mar 31, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
Mar 31, 2023 | Mar 28, 2023 |
| UPLOAD | Letter from the SEC | Mar 27, 2023 | — |
| S-3 | Shelf registration | Mar 16, 2023 | — |
| 8-K |
Current report
Other events
|
Mar 14, 2023 | Mar 14, 2023 |
| 10-Q | Quarterly report | Feb 9, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 9, 2023 | Feb 9, 2023 |
| DEFA14A | Additional proxy material | Jan 27, 2023 | — |
| DEF 14A | Proxy statement | Jan 27, 2023 | Mar 28, 2023 |
| 10-K | Annual report | Dec 5, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Dec 5, 2022 | Dec 5, 2022 |
| S-8 | Employee stock plan registration | Aug 11, 2022 | — |
| 10-Q | Quarterly report | Aug 11, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2022 | Aug 11, 2022 |
| S-8 | Employee stock plan registration | May 12, 2022 | — |
| 10-Q | Quarterly report | May 12, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 12, 2022 | May 12, 2022 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Mar 31, 2022 | Mar 29, 2022 |
| 10-Q | Quarterly report | Feb 9, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 9, 2022 | Feb 9, 2022 |
| DEFA14A | Additional proxy material | Jan 28, 2022 | — |
| DEF 14A | Proxy statement | Jan 28, 2022 | Mar 29, 2022 |
| 10-K | Annual report | Dec 2, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Dec 2, 2021 | Dec 2, 2021 |
| 10-Q | Quarterly report | Aug 12, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2021 | Aug 12, 2021 |
| 8-K |
Current report
Officer or director change
|
May 14, 2021 | May 10, 2021 |
| 10-Q | Quarterly report | May 12, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 12, 2021 | May 12, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Mar 26, 2021 | Mar 23, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 18, 2021 | Feb 17, 2021 |
| 424B5 | Prospectus supplement | Feb 18, 2021 | — |
| 424B5 | Prospectus supplement | Feb 17, 2021 | — |
| 10-Q | Quarterly report | Feb 10, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Feb 10, 2021 | Feb 10, 2021 |
| DEFA14A | Additional proxy material | Jan 28, 2021 | — |
| DEF 14A | Proxy statement | Jan 28, 2021 | Mar 23, 2021 |
| 10-K | Annual report | Dec 10, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Dec 9, 2020 | Dec 9, 2020 |
| EFFECT | Filing | Aug 14, 2020 | — |
| 424B5 | Prospectus supplement | Aug 13, 2020 | — |
| POS AM | Filing | Aug 13, 2020 | — |
| 10-Q | Quarterly report | Aug 13, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2020 | Aug 13, 2020 |
| EFFECT | Filing | Jul 1, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 30, 2020 | — |
| CORRESP | Letter to the SEC | Jun 30, 2020 | — |
| S-3 | Shelf registration | Jun 26, 2020 | — |
| 424B5 | Prospectus supplement | Jun 26, 2020 | — |
| 8-K |
Current report
Material agreement, Agreement ended
|
Jun 26, 2020 | Jun 26, 2020 |
| S-8 | Employee stock plan registration | May 13, 2020 | — |
| 10-Q | Quarterly report | May 13, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations
|
May 13, 2020 | May 13, 2020 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Mar 26, 2020 | Mar 24, 2020 |
| 10-Q | Quarterly report | Feb 12, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations
|
Feb 12, 2020 | Feb 12, 2020 |
| DEFA14A | Additional proxy material | Feb 11, 2020 | — |
| DEFA14A | Additional proxy material | Jan 28, 2020 | — |
| DEF 14A | Proxy statement | Jan 28, 2020 | Mar 24, 2020 |
| 10-K | Annual report | Dec 12, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Results of operations
|
Dec 12, 2019 | Dec 12, 2019 |
| 10-Q | Quarterly report | Aug 8, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2019 | Aug 8, 2019 |
| S-8 | Employee stock plan registration | May 15, 2019 | — |
| 10-Q | Quarterly report | May 15, 2019 | Mar 31, 2019 |
| 8-K |
Current report
Results of operations
|
May 15, 2019 | May 15, 2019 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Mar 29, 2019 | Mar 26, 2019 |
| 10-Q | Quarterly report | Feb 13, 2019 | Dec 31, 2018 |
| 8-K |
Current report
Results of operations
|
Feb 13, 2019 | Feb 13, 2019 |
| DEFA14A | Additional proxy material | Jan 28, 2019 | — |
| DEF 14A | Proxy statement | Jan 28, 2019 | Mar 26, 2019 |
| 8-K |
Current report
Other events
|
Dec 20, 2018 | Dec 18, 2018 |
| PRE 14A | Preliminary proxy statement | Dec 14, 2018 | Mar 26, 2019 |
| S-8 | Employee stock plan registration | Dec 13, 2018 | — |
| 10-K | Annual report | Dec 13, 2018 | Sep 30, 2018 |
| 8-K |
Current report
Results of operations
|
Dec 13, 2018 | Dec 13, 2018 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 27, 2018 | Sep 27, 2018 |
| 424B5 | Prospectus supplement | Sep 27, 2018 | — |
| 424B5 | Prospectus supplement | Sep 26, 2018 | — |
| 10-Q | Quarterly report | Aug 14, 2018 | Jun 30, 2018 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2018 | Aug 14, 2018 |
| 8-K |
Current report
Officer or director change
|
Jun 1, 2018 | May 25, 2018 |
| 10-Q | Quarterly report | May 11, 2018 | Mar 31, 2018 |
| 8-K |
Current report
Results of operations
|
May 9, 2018 | May 9, 2018 |
| 8-K |
Current report
Bylaw or fiscal year change
|
May 4, 2018 | May 2, 2018 |
| 8-K |
Current report
Officer or director change
|
Apr 20, 2018 | Apr 16, 2018 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Mar 26, 2018 | Mar 20, 2018 |
| 8-K |
Current report
Material agreement, New debt
|
Mar 6, 2018 | Mar 5, 2018 |
| 10-Q | Quarterly report | Feb 14, 2018 | Dec 31, 2017 |
| 8-K |
Current report
Results of operations
|
Feb 14, 2018 | Feb 14, 2018 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VERU (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- WI
- Headquarters
- Miami, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 863894
- Former names
- FEMALE HEALTH CO (until Aug 1, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.